D.C. Circuit Rejects FTC’s Appeal Related To Alleged Anticompetitive Conduct Stemming From Endo And Impax’s Patent Settlement Agreement, Holding It Was No Different From A Permissible Exclusive Licensing Agreement
Blog
Antitrust Litigation
On August 25, 2023, a panel of the United States Court of Appeals for the D.C Circuit affirmed the district court's dismissal of the FTC's complaint…
Popular articles from this firm
